Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Stage IIA1 versus stage IIA2 cervical cancer: does the new staging criteria predict survival?
Gunjal Garg; Jay P Shah; Eugene P Toy; Carl Christensen; Gunter Deppe; Radwan Asaad; Robert T Morris (Profiled Authors: Carl Woodrow Christensen; Gunter Deppe; Robert Thomas Morris)
Department of Obstetrics and Gynecology, Detroit Medical Center, Detroit, MI, USA. gunjalgarg@yahoo.com
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2011;21(4):711-6.
OBJECTIVE: (1) To determine the correlation of 2008 International Federation of Gynecology and Obstetrics staging system with survival in patients with stage IIA cervical cancer, (2) to elucidate the treatment patterns in stage IIA1 and stage IIA2 cervical cancer, and (3) to investigate whether radical hysterectomy or radiation influenced overall survival. METHODS: Data were extracted from the Surveillance, Epidemiology and End Results database between 1988 and 2005. Statistical analysis used χ test, Kaplan-Meier method, Cox regression, and logistic regression. RESULTS: Of the 560 women, 271 (48.4%) had stage IIA1, and 289 (51.6%) had stage IIA2 cervical cancer. Stage IIA2 patients were younger than stage IIA1 patients (mean age, 49 years vs 54 years; P = 0.01). Stage IIA1, compared with stage IIA2, differed significantly regarding the administration of primary radiation (47.2% vs 64.7%, P < 0.001) and adjuvant radiation (60.5% vs 77.5%, P = 0.006). The following variables were significantly associated with the performance of radical hysterectomy: patient age, 65 years or younger, tumor size, ≤ 2 cm or lesser, high tumor grade, and nonsquamous tumor histology. The incidence of adjuvant radiation after radical hysterectomy was high (48% [tumor size, ≤ 2 cm] to 86% [tumor size, >6 cm]). The 5-year overall survival was not significantly different between stages IIA1 and IIA2 (65.8% vs 59.5%, P = 0.2). Only patient age (P = 0.01), tumor size (P = 0.02), and lymph node status (P = 0.002) were independent predictors of survival. When controlled for other contributing factors, there was no significant difference in survival between patients treated by radical hysterectomy and primary radiation. CONCLUSIONS: The 2008 International Federation of Gynecology and Obstetrics staging criteria is not an independent predictor of survival in stage IIA cervical cancer. Given the equivalent efficacy of radical hysterectomy and radiation, attention should be paid to the high risk of adjuvant radiation in these patients.
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Grants
-
1.
Lancaster, Wayne D
HPV INTEGRATION AS A BIOMARKER FOR CIN BEHAVIOR
3 July 2002 - 30 June 2005
NATIONAL CANCER INSTITUTE
Total Funding: $ 149,000
-
2.
SCHWARTZ, ANN
Surveillance, Epidemiology and End Results (SEER) Program - Wayne State
1 August 2003 - 31 July 2010
NATIONAL CANCER INSTITUTE
-
3.
SCHWARTZ, ANN
TAS::75 0849::TAS SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM
1 August 2010 - 29 September 2011
NATIONAL CANCER INSTITUTE
Related Publications
-
1.
2010Karynsa Cetin; Jennifer L Beebe-Dimmer; Jon P Fryzek; Richard Markus; Michael A Carducci
Urology 2010;75(6):1396-404. -
2.
2002Merlin R Hamre; Richard K Severson; Paul Chuba; David R Lucas; Ron L Thomas; Michael P Mott
Osteosarcoma as a second malignant neoplasm.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2002;65(3):153-7. -
3.
2005Laurel A Copeland; Mohamed A Elshaikh; James Jackson; Louis A Penner; Willie Underwood
Cancer 2005;104(7):1372-80.
Related Topics
Appears in this Publication
Related Experts
Author of this Publication
-
Internal ExpertsPublications
-
64









-
190









-
159









-
119









-
65









-
46










